Shionogi's tender offer for Torii Pharmaceutical succeeds

Shionogi Pharmaceutical's tender offer for Torii Pharmaceutical (TSE:4551) concluded on June 18, 2025, with the total number of shares tendered exceeding the minimum planned, thus ensuring the offer's success. As a result of the tender offer, which saw 10,977,091 Torii shares tendered, Shionogi is expected to become a major shareholder and an affiliated company of Torii on June 25, 2025. This will give Shionogi a voting rights ratio of over 20%. Shionogi now owns 109,770 thousand Torii shares, or 39.04%